Price:
Rs. 7,299.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: J0004
Frequently Asked Questions (FAQ's):
What does the JAK2 V617F Mutation Detection test include?
This test analyzes EDTA blood to detect the JAK2 V617F mutation associated with various myeloproliferative disorders.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated RT-PCR protocols under strict quality control to ensure highly sensitive and specific mutation detection.
Who should take this test?
Individuals with elevated blood counts, suspected MPNs, or unexplained thrombotic events may be advised to undergo this test.
What sample type is required?
An EDTA blood sample is required for accurate and reliable genetic testing.
Why is detecting the JAK2 V617F mutation important?
It aids in confirming the diagnosis of MPNs, guiding treatment decisions, and assessing disease prognosis.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare ensures high accuracy through advanced RT-PCR methods, stringent quality control, and expert interpretation.
Is any preparation needed before the test?
No fasting or special preparation is required; patients should follow any physician instructions provided.
How soon are results available?
Turnaround time may vary, but Metropolis Healthcare typically provides prompt results to support early diagnosis and management.